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Favorable therapeutic effects of isoniazids on pulmonary tuberculosis were
widely publicized in the lay press early in 1952 with the customary dramatic
splash of journalism. Since then there have appeared in medical journals many
conservative reports of proper scientific quality that recount beneficial effects
from these drugs in pulmonary tuberculosis (la, b, c, d), genito-urinary tuberculo-




DIAGNOSIS _______________________ ________ REMARKS
No. % No. % No. %
Lupus vulgaris 12 4 33 5 42 3 25 Of great value
Tuberculosis eutis
induratum 7 5 70 2 30 Of great value
Tuberculosis cutis
colliquativa 1 1 100 Of great value
Leprosy 3* 3 100 Of value
Discoid lupus
erythematosus 3 3 100 Of no apparent value
Tuberculid of face 1 1 100 Of no apparent value
Sarcoidosis
F
4 100 Of no apparent value
Mycosis fungoides 1 1 100 Of no apparent value
Lymphocytoma 1 1 100 Of no apparent value
* 2 cases were of the lepromatous variety; one was tuberculoid.
In the matter of cutaneous tuberculosis, up to this writing the American
literature contains, to our knowledge, but three reports. Obermayer, Wilson and
Smith (4a) reported one case of lupus vulgaris successfully treated with Rimifon®
and Goldberg and Simon (4b) reported two equally successful cases. Cordero,
in an informal report (4c), recounts treatment of fifteen patients with several
conditions, of which ten were true tuberculosis cutis, one was a tuber-
culid (Lewandowsky), one was sarcoid of Boeck, two were lupus erythematosus
* From the Department of Dermatology and Syphilology of the New York University
Post-Graduate Medical School (Marion B. Sulzberger, M.D., Chairman) and the Skin and
Cancer Unit of the New York University Hospital.
t Some of the cases were drawn from the Service of Dermatology and Syphilology of
Bellevue Hospital (Frank C. Combes, M.D., Chief of Service).







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































54 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
and one was a deep mycosis (sporotrichosis). According to Cordero all the tuber-
culoderms including the rosacea-like tuberculid of Lewandowsky responded well
but lupus erythematosus, sporotrichosis and sarcoid of Boeck did not. In addi-
tion to all of the above, sporadic cases of similar nature are now being shown
from time to time at dermatologic meetings and reports of them will probably
appear in the published proceedings of various societies.
FIG. 1. Lupus vulgaris before treatment. (Case 1., R. S.)
The Therapeutic Section of the Skin and Cancer Unit and the Bellevue Service
of the Department of Dermatology and Syphilology of the New York Uni-
versity Post-Graduate Medical School have had experience with the use of
isonicotinylhydrazine* in some 33 cases of various dermatoses, two thirds of
which were tuberculoderms. Our object in undertaking this study was to obtain
* Generous supplies of Rimif On® were made available to us by Hoffmann-La Roche,
Inc. through the good offices of Dr. Leo Pirk.
t1
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a relatively quick impression of the worth of the drug in tuberculosis cutis, in
other granulomatous processes of known cause and in some conditions that are
of unknown cause and of notorious recalcitrance to treatment. No more elaborate
laboratory studies were performed beyond what the conditions required for
diagnosis, what was further required for routine medical reasons and finally, what
Fin. 2. Lupus vulgaris after treatment. (Case 1., R. S.)
seemed reasonable for early revelation of possible toxicity that would not be
clearly evident to good clinical observation. The pertinent data about the cases
and the results of treatment are summarized in Tables I and II.
DISCUSSION
Therapeutic assays in conditions that have precise criteria of change in the
form of simple laboratory determinations or indisputable clinical evidence, like
rapid falls in temperature or quick resolution of visible lesions, are fairly easy and
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convincing. In conditions whose progress or worsening is slow and not reflected
in laboratory findings or sharp and sudden clinical changes, therapeutic assays
are much more difficult to conduct. Such are the conditions that have been dealt
with here and the difficulties are as stated. Yet, despite the general uncertainty
of clinical judgments in slow moving processes, in the cases studied, changes for
the better (or worse) could be read clinically in weeks or months with a feeling of
reasonable certainty.
Thus it can be seen from the tables that tuberculosis cutis luposa (lupus vu!-
garis), tuberculosis cutis indurativa (Bazin's disease), and tuberculosis cutis
colliquativa (scrofuloderma) responded favorably to isonicotinyihydrazine
whereas discoid lupus erythematosus, sarcoidosis, mycosis fungoides and lympho-
cytoma did not. Percentage-wise, lupus vulgaris responded in grades of excellent
to good in 75 % of the cases; Bazin's disease and scrofuloderma responded well
in all cases. In the cases of leprosy, judgments about the therapeutic effects of
agents must, of course, be qualified and guarded. In the three cases of this study,
the case of tuberculoid leprosy resolved as far as can be told clinically during
the period of administration of Rimifon® and the two lepromatous cases showed
flattening of raised lesions which all observers agreed upon, although smears
could always be taken to show typical acid fast rods. Finally it remains to remark
that in those conditions where the isoniazid seemed ineffective, the number of
cases is obviously too small to make conclusions with confidence.
If one may speculate from the kind and the spread of the results in this study,
isonicotinylhydrazine seems to have a significant effect on mycobacterial infec-
tions, particularly in infections with M. tuberculosis and most particularly on
those of them that presumably contain living organisms in relative abundance.
SUMMARY AND CONCLUSIONS
1. Thirty three cases of various dermatologic conditions, mainly tuberculo-
derms, were treated with isonicotinylhydrazine.
2. Isonicotinyihydrazine is a valuable agent in the management of certain
mycobacterial infections, particularly of M. tuberculosis and possibly of M.
leprae.
3. Reactions from treatment were few, of minor character and rarely neces-
sitated interruption of treatment.
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